genprowebdirectory
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Insights
Trends for 2020
Trends for 2021
Trends for 2023
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
GEN – Genetic Engineering and Biotechnology News
GEN Edge
Featured News
Multimedia
Subscribe
Login
Contributors
News
Artificial Intelligence
Machine Learning Can Speed Search for Biopharmaceuticals for Oral Delivery
Genomics
Sand, Sea, and Sequencing: Julianna LeMieux Surfs up AGBT’s Hot News
Biologics
Early Anti-VEGF Treatment of Diabetic Retinopathy Does Not Benefit Visual Acuity,…
Cancer
Strata Oncology Validates Clinical Utility of Solid Tumor Predictive Biomarker
Diabetes
Novel Approach Reduces Diabetic Kidney Disease Progression
Insights
All
Trends for 2020
Trends for 2021
Trends for 2023
Artificial Intelligence
Machine Learning Can Speed Search for Biopharmaceuticals for Oral Delivery
Bioprocessing
Out-of-Balance Manufacturing Challenges Bioindustry CFOs
Bioprocessing
University Creates Innovative Model for Running a GMP Manufacturing Facility
Bioprocessing
Monitoring Biomanufacturing Systems and Operations More Effectively
Topics
Artificial Intelligence
Bioprocessing
Cancer
Drug Discovery
Genome Editing
Infectious Diseases
OMICs
Translational Medicine
A-Lists
Drug Discovery
Seven Biopharma Trends to Watch in 2023
A-Lists
Top 50 NIH-Funded Institutions of 2022
A-Lists
Top 10 U.S. Biopharma Clusters
A-Lists
Top 10 Spatial Biology Companies
A-Lists
Top 25 Biotech Companies of 2022
Magazine
Current Issue
Past Issues
Supplements
Subscribe
Multimedia
Summits
Webinars
Learning Labs
GEN Live
Podcasts
Resources
eBooks/Perspectives
Tutorials
Biotech Briefs
Peer-Reviewed Journals
GEN Biotechnology
Re:Gen Open
New Products
Best of the Web
Best Apps
Conference Calendar
Subscribe
Get GEN Magazine
Get GEN eNewsletters
Get GEN Edge
Home
Companies
Roche
Roche
23andMe
Abbvie
AdnaGen
Agilent Technologies
Alexion Pharmaceuticals
Amgen
Astellas
AstraZeneca
Audentes Therapeutics
Berkeley Lights
Bio-Rad Laboratories
Biogen
Cancer Genetics
Catalent
Charles RIver Laboratories
Dana-Farber Cancer Institute
deCODE genetics
Dicerna
Dimension Therapeutics
Exact Sciences
Foundation Medicine
GE Healthcare
GeneInsight
Gilead Sciences
GlaxoSmithKline
Halozyme Therapeutics
Hitachi High-Technologies
Horizon Discovery Group
Human Longevity
Illumina
Jackson Laboratory
Janssen Biotech
LabCorp
Maravai LifeSciences
MD Anderson
MDxHealth
MedImmune
Memorial Sloan Kettering Cancer Center
Merck & Co
Merck KGaA
NanoString Technologies
Novartis
Pathology
PerkinElmer
PersonalizeDx
Qiagen
RayBiotech
Roche
Sanofi
shire
Sigma-Aldrich
Synthego
Takeda
Thermo Fisher Scientific
UCB Biosciences
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Oncologics
Olema Plans Pivotal Trial for Two-Prong Breast Cancer Treatment
Blood Disorders
Rising Star: Vega Targets Rare Blood Disorders with Antibodies
Alzheimers
StockWatch: Analysts Sour on Roche after Alzheimer’s Clinical Failure
Alzheimers
StockWatch: Biogen Shares Rebound as Alzheimer’s Drug Aces Phase III Trial
Gene Therapy
New Spark: Successor to Build on Work of Departing CEO Jeffrey Marrazzo
Liquid Biopsies
Blood Stake: Roche Raises Freenome Investment to $360M
Cell Therapy
Lineage 2.0: Cell Therapy Developer Eyes Next Phase after Genentech Collaboration...
Gene Therapy
Spark Therapeutics Plans $575M Philadelphia Gene Therapy Center
Artificial Intelligence
Roche, Genentech, Recursion Launch Up-to-$12B AI Drug Discovery Effort
Roche
U.S. OKs EUA for Genentech’s Actemra vs. COVID-19; Halts Distribution of...
Roche
Mountain Climbing: Dyno Fights AAV Vector Immune Response with $100M
Roche
Genentech Launches $1B+ RNA Collaboration with Ribometrix
Roche
Roche and Blueprint Medicines Launch Up-to-$1.7B Partnership to Develop Cancer Drug...
Roche
Phase III Trial to Study Combination of Genentech’s Actemra, Gilead’s Remdesivir...
Roche
Genentech Launches Phase III Trial of Actemra as Coronavirus Treatment
1
2
3
...
5
Page 1 of 5
Scroll Up
Login
Subscribe